Tenaya Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Assets
Tenaya Therapeutics, Inc. (TNYA) reported Increase (Decrease) in Other Noncurrent Assets of -$424.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-05
- Tenaya Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $37.00K.
- Tenaya Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$461.00K.
- Tenaya Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $2.00K.
- Tenaya Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$65.00K.
- Tenaya Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was -$571.00K.
- Tenaya Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was -$656.00K, a 209.15% decline from fiscal 2023.
- Tenaya Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was $601.00K, a 26.26% decline from fiscal 2022.
- Tenaya Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was $815.00K, a 73.83% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$424.00K 10-Q · filed 2026-08-05 | -$422.00K derived: sum of 3 quarters · filed 2026-08-05 | -$487.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$461.00K 10-Q · filed 2026-05-06 | -$459.00K derived: sum of 2 quarters · filed 2026-05-06 | -$524.00K derived: sum of 3 quarters · filed 2026-05-06 | -$1.03M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$63.00K derived: sum of 2 quarters · filed 2026-03-11 | -$567.00K derived: sum of 3 quarters · filed 2026-08-05 | -$571.00K 10-K · filed 2026-03-11 |
| 2025-09-30 | -$65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$569.00K derived: sum of 2 quarters · filed 2026-08-05 | -$573.00K 10-Q · filed 2025-11-10 | -$629.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$504.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$508.00K 10-Q · filed 2026-08-05 | -$564.00K derived: sum of 3 quarters · filed 2026-08-05 | -$813.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$4.00K 10-Q · filed 2026-05-06 | -$60.00K derived: sum of 2 quarters · filed 2026-05-06 | -$309.00K derived: sum of 3 quarters · filed 2026-05-06 | -$610.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$305.00K derived: sum of 2 quarters · filed 2026-03-11 | -$606.00K derived: sum of 3 quarters · filed 2026-03-11 | -$656.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | -$249.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$550.00K derived: sum of 2 quarters · filed 2025-11-10 | -$600.00K 10-Q · filed 2025-11-10 | -$657.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$351.00K 10-Q · filed 2025-08-06 | -$408.00K derived: sum of 3 quarters · filed 2025-08-06 | -$476.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$50.00K 10-Q · filed 2025-05-07 | -$107.00K derived: sum of 2 quarters · filed 2025-05-07 | -$175.00K derived: sum of 3 quarters · filed 2025-05-07 | $714.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | -$57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | -$125.00K derived: sum of 2 quarters · filed 2025-03-10 | $764.00K derived: sum of 3 quarters · filed 2025-03-10 | $601.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | -$68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $821.00K derived: sum of 2 quarters · filed 2024-11-06 | $658.00K 10-Q · filed 2024-11-06 | $801.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $889.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $726.00K 10-Q · filed 2024-08-08 | $869.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.41M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$163.00K 10-Q · filed 2024-05-14 | -$20.00K derived: sum of 2 quarters · filed 2024-05-14 | $520.00K derived: sum of 3 quarters · filed 2024-05-14 | $677.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $683.00K derived: sum of 2 quarters · filed 2024-03-18 | $840.00K derived: sum of 3 quarters · filed 2024-03-18 | $815.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $540.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $697.00K derived: sum of 2 quarters · filed 2023-11-08 | $672.00K 10-Q · filed 2023-11-08 | $723.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $132.00K 10-Q · filed 2023-08-09 | $183.00K derived: sum of 3 quarters · filed 2023-08-09 | $292.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$25.00K 10-Q · filed 2023-05-10 | $26.00K derived: sum of 2 quarters · filed 2023-05-10 | $135.00K derived: sum of 3 quarters · filed 2023-05-10 | -$224.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $160.00K derived: sum of 2 quarters · filed 2023-03-08 | -$199.00K derived: sum of 3 quarters · filed 2023-03-08 | $3.11M 10-K · filed 2023-03-08 |
| 2021-09-30 | $109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$250.00K derived: sum of 2 quarters · filed 2022-11-10 | $3.06M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$359.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $2.95M 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | $3.31M 10-Q · filed 2022-05-11 | |||
| 2020-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $168.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $181.00K 10-Q · filed 2021-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |